Goldman Sachs Group Inc Sutro Biopharma, Inc. Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
A detailed history of Goldman Sachs Group Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 802,735 shares of STRO stock, worth $3.39 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
802,735
Previous 1,060,582
24.31%
Holding current value
$3.39 Million
Previous $4.55 Million
0.31%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding STRO
# of Institutions
123Shares Held
53.3MCall Options Held
7.8KPut Options Held
2.4K-
Suvretta Capital Management, LLC New York, NY5.78MShares$24.4 Million1.4% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$24.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.74MShares$20 Million0.01% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.1MShares$17.3 Million3.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.02MShares$12.8 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $220M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...